Literature DB >> 2419770

Agonist-antagonist properties of fluorescent opioid probes in the guinea-pig myenteric plexus-longitudinal muscle preparation.

A Koman, M Einarsson, L Terenius.   

Abstract

The opioid activity of a series of fluorescent derivatives of oxymorphone, naloxone and naltrexone, were characterized on the electrically stimulated guinea-pig myenteric plexus-longitudinal muscle preparation. In all compounds the fluorescent moiety, fluorescein or tetramethylrhodamine B, is attached to the C-6 carbon of the morphinan. Mu-receptor affinity was well retained and there was a good correlation between capacity to displace [3H]-dihydromorphine from binding sites in rat brain membranes and apparent receptor affinity in the myenteric plexus measured as antagonism of normorphine effects. Fluorescein conjugated oxymorphone showed mainly agonist activity. Certain derivatives of the antagonists naloxone and naltrexone showed partial agonism. One compound, 1-(N)-fluoresceinyl naloxone thiosemicarbazone, was an antagonist.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2419770     DOI: 10.1007/bf00500819

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Stereospecific synthesis of the 6beta-hydroxy metabolites of naltrexone and naloxone.

Authors:  N Chatterjie; C E Inturrisi
Journal:  J Med Chem       Date:  1975-05       Impact factor: 7.446

2.  Opiate (Enkephalin) receptors of neuroblastoma cells: occurrence in clusters on the cell surface.

Authors:  E Hazum; K J Chang; P Cuatrecasas
Journal:  Science       Date:  1979-11-30       Impact factor: 47.728

Review 3.  In vitro models in the study of structure-activity relationships of narcotic analgesics.

Authors:  H W Kosterlitz; A A Waterfield
Journal:  Annu Rev Pharmacol       Date:  1975       Impact factor: 13.820

4.  The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.

Authors:  J Magnan; S J Paterson; A Tavani; H W Kosterlitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

Review 5.  Classification of opioid receptors.

Authors:  S J Paterson; L E Robson; H W Kosterlitz
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

6.  Fluorescent enkephalin derivatives with biological activity.

Authors:  M C Fournie-Zaluski; G Gacel; B P Roques; B Senault; J M Lecomte; B Malfroy; J P Swerts; J C Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1978-07-14       Impact factor: 3.575

Review 7.  Narcotic analgesics and antagonists.

Authors:  J W Lewis; K W Bentley; A Cowan
Journal:  Annu Rev Pharmacol       Date:  1971       Impact factor: 13.820

8.  Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum.

Authors:  E A Gyand; H W Kosterlitz
Journal:  Br J Pharmacol Chemother       Date:  1966-09

9.  Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).

Authors:  H W Kosterlitz; A J Watt
Journal:  Br J Pharmacol Chemother       Date:  1968-06

10.  The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum.

Authors:  H W Kosterlitz; R J Lydon; A J Watt
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

View more
  3 in total

1.  Naloxone-6 alpha-spirohydantoin: a long-acting opiate antagonist.

Authors:  G J Alexander; N Chatterjie
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

2.  A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro.

Authors:  A Koman; V M Kolb; L Terenius
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

3.  Prolonged receptor blockade by opioid receptor probes.

Authors:  A Koman; V M Kolb; L Terenius
Journal:  Pharm Res       Date:  1986-02       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.